<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Description of interventions_5</title>
    <link href="data:image/x-icon;base64,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" rel="icon" type="image/x-icon">
    <style>@import "https://fonts.googleapis.com/css?family=Source+Sans+Pro:ital,wgth:0,400;0,700;1,400;1,700";body {  font-family: "Source Sans Pro", sans-serif;  margin: 40px;}@media screen {  #backToTop {    position: fixed;    bottom: 0px;    left: 50%;    transform: translateX(-50%);    border-radius: 4px 4px 0 0;    padding: 4px 12px 4px 12px;    background: #1f3c73;    font-weight: bold;  }  #backToTop a {    color: white;  }}@media print {  #backToTop {    display: none;  }}table {  width: fit-content;  border-collapse: collapse;}th {  font-weight: bold;  background: LightGray;}td, th {  border: 1px solid LightGray;  padding: 8px;  font-size: 14px;  vertical-align: top;}caption {  font-weight: bold;  font-size: large;  text-align: left;  padding: 8px;}h1 {  font-size:38.5px;}h2 {  font-size:31.5px;}h1 small, h3 {  font-size:24.5px;}h2 small, h4 {  font-size:17.5px;}h3 small, h4 small, h5 {  font-size:14px;}h6 {  font-size:11.9px;}a {  color: #002d64;  text-decoration: none;}.byline {  font-weight: bold;  color: #002D64;}.disclaimer {  font-style: italic;}figure, table.analysis {  width: fit-content;  display: block;  margin-block-start: 1em;  margin-block-end: 1em;  margin-inline-start: 40px;  margin-inline-end: 40px;}thead tr td, th, figcaption, caption {  font-weight: bold;  background: LightGray;}span.inserted {  background-color: #e5ffcd;}span.deleted {  background-color: #e5ffcd;  text-decoration: line-through;}span.marker-yellow {  background-color: #ffff80;}ol ol {  list-style-type: lower-alpha;}ol ol ol {  list-style-type: lower-roman;}</style>
  </head>
  <body>
    <div class="logo">
      <svg xmlns="http://www.w3.org/2000/svg" height="57" viewBox="0 0 1138.5 192" width="338" xml:space="preserve">
        <path d="M86 .5v33a63.3 63.3 0 0 0 0 125v33a96 96 0 0 1 0-191zM106 .5v33a63.3 63.3 0 0 1 0 125v33a96 96 0 0 0 0-191z" fill="#1f3c73"></path>
        <path d="M93 0h6v192h-6z" fill="#a53995"></path>
        <path d="M93 0h6v192h-6zM82 44h8v6h-8z" fill="#a53995"></path>
        <path d="M63 58h40v6H63zM69 73h30v6H69zM78 86h36v6H78zM63 100h42v6H63zM60 114h28v6H60zM88 128h15v6H88zM84 140l6 6-6 6-6-6z" fill="#a53995"></path>
        <g aria-label="Cochrane" fill="#1f3c73" stroke-width="3.368">
          <path d="M256.96 82.722q-7.366 0-13.564-3.413-6.198-3.414-9.97-10.06-3.683-6.737-3.683-16.528 0-9.701 3.772-16.528 3.863-6.917 10.15-10.51 6.378-3.682 13.743-3.682 5.66 0 10.15 2.335 4.492 2.246 7.456 5.3l-7.007 8.443q-2.245-2.066-4.76-3.323-2.426-1.347-5.57-1.347-3.952 0-7.275 2.245-3.234 2.246-5.21 6.468-1.886 4.221-1.886 10.15 0 8.982 3.862 14.013 3.863 5.03 10.33 5.03 3.593 0 6.378-1.617 2.874-1.617 5.03-3.863l7.006 8.264q-7.365 8.624-18.953 8.624zM302.86 82.722q-5.659 0-10.689-2.695-4.94-2.784-7.994-7.994-3.054-5.3-3.054-12.665 0-7.456 3.054-12.665 3.054-5.21 7.994-7.905 5.03-2.784 10.689-2.784t10.599 2.784q4.94 2.695 7.994 7.905 3.054 5.21 3.054 12.665 0 7.365-3.054 12.665-3.054 5.21-7.994 7.994-4.94 2.695-10.599 2.695zm0-10.689q4.042 0 6.108-3.413 2.066-3.504 2.066-9.252 0-5.839-2.066-9.252-2.066-3.413-6.108-3.413-4.132 0-6.198 3.413-1.976 3.413-1.976 9.252 0 5.749 1.976 9.252 2.066 3.413 6.198 3.413zM352.98 82.722q-6.198 0-11.228-2.695-4.94-2.784-7.905-7.994-2.874-5.3-2.874-12.665 0-7.456 3.234-12.665 3.233-5.21 8.533-7.905 5.3-2.784 11.408-2.784 4.132 0 7.276 1.347 3.234 1.348 5.749 3.413l-6.198 8.534q-3.144-2.605-6.018-2.605-4.761 0-7.636 3.413-2.784 3.413-2.784 9.252 0 5.749 2.784 9.252 2.875 3.413 7.186 3.413 2.156 0 4.222-.898 2.066-.988 3.773-2.335l5.21 8.623q-3.324 2.874-7.186 4.132-3.863 1.167-7.546 1.167zM375.53 81.644V18.677h13.204v15.45l-.629 7.994q2.515-2.245 5.839-4.131 3.413-1.977 7.904-1.977 7.276 0 10.51 4.85 3.323 4.762 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.091zM426.82 81.644V37.091h10.779l.898 7.815h.36q2.425-4.491 5.838-6.647 3.413-2.246 6.827-2.246 1.886 0 3.144.27 1.257.18 2.156.628l-2.156 11.408q-1.168-.359-2.336-.539-1.078-.18-2.515-.18-2.515 0-5.3 1.887-2.694 1.797-4.49 6.288v25.869zM471.28 82.722q-6.108 0-9.701-3.862-3.593-3.953-3.593-9.612 0-7.006 5.928-10.959 5.929-3.952 19.133-5.3-.18-2.964-1.796-4.67-1.527-1.797-5.21-1.797-2.785 0-5.659 1.078-2.874 1.078-6.108 2.964l-4.76-8.713q4.221-2.605 8.982-4.222 4.85-1.616 10.06-1.616 8.533 0 13.114 4.94 4.58 4.94 4.58 15.18v25.51h-10.778l-.898-4.581h-.36q-2.784 2.515-6.018 4.132-3.144 1.527-6.916 1.527zm4.491-10.24q2.246 0 3.863-.988 1.706-1.078 3.413-2.785v-7.814q-7.006.898-9.701 2.874-2.695 1.886-2.695 4.491 0 2.156 1.348 3.234 1.437.988 3.772.988zM507.39 81.644V37.091h10.779l.898 5.659h.36q2.874-2.695 6.287-4.671 3.503-2.066 7.995-2.066 7.275 0 10.509 4.85 3.323 4.761 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.09zM578.71 82.722q-6.378 0-11.498-2.785-5.12-2.784-8.084-7.994-2.964-5.21-2.964-12.575 0-7.276 2.964-12.486 3.054-5.21 7.904-7.994 4.85-2.875 10.15-2.875 6.378 0 10.51 2.875 4.221 2.784 6.287 7.635 2.156 4.76 2.156 10.869 0 1.706-.18 3.413-.18 1.617-.36 2.425h-26.677q.898 4.85 4.042 7.186 3.144 2.246 7.545 2.246 4.761 0 9.612-2.964l4.4 7.994q-3.412 2.335-7.634 3.683-4.222 1.347-8.174 1.347zm-9.88-28.205h16.078q0-3.683-1.796-6.018-1.707-2.426-5.66-2.426-3.053 0-5.479 2.156-2.425 2.066-3.143 6.288z"></path>
        </g>
        <g aria-label="Library" fill="#a53995" stroke-width="3.368">
          <path d="M236.48 168.68v-58.925h7.455v52.547h25.78v6.378zM279.42 168.68v-43.655h7.366v43.655zm3.773-52.637q-2.156 0-3.593-1.258-1.348-1.347-1.348-3.593 0-2.155 1.348-3.503 1.437-1.347 3.593-1.347 2.155 0 3.503 1.347 1.437 1.348 1.437 3.503 0 2.246-1.437 3.593-1.348 1.258-3.503 1.258zM320.82 169.76q-3.054 0-6.378-1.437-3.233-1.527-6.108-4.132h-.27l-.628 4.491h-5.928v-63.955h7.365v17.426l-.18 7.905q2.965-2.605 6.468-4.312 3.593-1.796 7.186-1.796 8.533 0 12.935 6.018 4.401 6.018 4.401 16.168 0 7.455-2.694 12.755-2.605 5.3-6.917 8.084-4.222 2.785-9.252 2.785zm-1.258-6.198q5.39 0 8.893-4.58 3.593-4.672 3.593-12.756 0-7.186-2.695-11.587-2.605-4.491-8.803-4.491-2.784 0-5.659 1.527-2.874 1.527-6.018 4.401v22.905q2.875 2.515 5.66 3.593 2.874.988 5.03.988zM351.19 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.899-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM390.26 169.76q-5.48 0-9.162-3.234-3.593-3.323-3.593-9.162 0-7.186 6.377-10.959 6.468-3.862 20.39-5.39 0-2.784-.808-5.299-.719-2.515-2.695-4.042-1.886-1.617-5.479-1.617-3.773 0-7.096 1.437-3.324 1.438-5.928 3.234l-2.875-5.12q3.054-1.976 7.456-3.773 4.49-1.886 9.7-1.886 7.995 0 11.588 4.94 3.593 4.851 3.593 13.026v26.768h-6.108l-.63-5.21h-.269q-3.054 2.515-6.736 4.401-3.593 1.886-7.725 1.886zm2.156-5.928q3.144 0 5.928-1.527 2.785-1.527 5.929-4.312v-12.126q-10.87 1.347-15.27 4.042-4.312 2.695-4.312 6.917 0 3.682 2.246 5.39 2.245 1.616 5.479 1.616zM425.47 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.898-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM459.6 187.45q-1.437 0-2.785-.27-1.257-.269-2.335-.628l1.437-5.839q.719.18 1.617.36.898.269 1.707.269 3.683 0 6.108-2.695 2.425-2.605 3.772-6.647l.988-3.233-17.516-43.745h7.636l8.892 24.163q.988 2.784 2.066 6.018 1.168 3.233 2.156 6.287h.36q.987-2.964 1.886-6.197.898-3.234 1.796-6.109l7.815-24.163h7.186l-16.438 47.248q-1.527 4.312-3.683 7.725-2.066 3.414-5.21 5.39-3.054 2.066-7.455 2.066z"></path>
        </g>
        <g aria-label="Trusted evidence." fill="#1f3c73" stroke-width="3.368">
          <path d="M710.25 61.723V30.141h-10.671v-3.773h25.869v3.773h-10.671v31.582zM728.9 61.723V35.53h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM755.25 62.37q-4.15 0-6.09-2.587-1.94-2.64-1.94-7.653v-16.6h4.473v16.007q0 3.665 1.132 5.336 1.185 1.67 3.772 1.67 2.048 0 3.611-1.024 1.617-1.078 3.45-3.395V35.53h4.42v26.193h-3.666l-.377-4.096h-.162q-1.832 2.156-3.88 3.45-2.048 1.293-4.743 1.293zM783.76 62.37q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.294-1.24 1.294-2.91 0-1.348-.917-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.186-1.832-.7-3.61-1.562-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862t3.61 2.102l-2.155 2.802q-1.347-1.024-2.803-1.67-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.809 2.049.808.754 2.101 1.347 1.294.539 2.749 1.132 1.886.7 3.719 1.617 1.832.862 3.018 2.371 1.24 1.455 1.24 3.934 0 2.102-1.132 3.88-1.078 1.78-3.234 2.857-2.102 1.078-5.228 1.078zM806.67 62.37q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306V39.141h-3.88V35.8l4.095-.27.54-7.33h3.718v7.33h7.06v3.61h-7.06v14.553q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.509-.216l1.455-.485.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM826.5 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM851.56 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.886 7.384 1.887 2.64 5.336 2.64zM893.92 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM915.97 61.723l-9.432-26.193h4.581l4.959 14.875 1.185 3.88q.647 1.94 1.24 3.827h.216q.592-1.886 1.185-3.827.647-1.94 1.186-3.88l4.958-14.875h4.366l-9.27 26.193zM935.48 61.723V35.53h4.42v26.193zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM957.68 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.887 7.384 1.886 2.64 5.335 2.64zM989.26 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1005.4 61.723V35.53h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42V45.715q0-3.665-1.185-5.335t-3.773-1.671q-1.994 0-3.61 1.024-1.563 1.024-3.558 3.018v18.971zM1045.2 62.37q-3.45 0-6.252-1.617t-4.42-4.689q-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM1068.9 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.707 3.341 2.748 3.342 2.748 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.678q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1087.4 62.37q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Informed decisions." fill="#1f3c73" stroke-width="3.368">
          <path d="M699.58 124.7V89.345h4.473V124.7zM713.32 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM743.56 124.7v-22.582h-3.557v-3.341l3.557-.27v-4.15q0-3.988 1.832-6.306 1.887-2.371 5.821-2.371 1.24 0 2.371.27 1.132.215 1.995.592l-.97 3.396q-1.456-.647-2.965-.647-3.665 0-3.665 5.066v4.15h5.552v3.61h-5.552V124.7zM768.19 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69t-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.102 2.748 5.443 2.748zM787.21 124.7V98.507h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689V124.7zM805.91 124.7V98.507h3.665l.377 3.773h.162q1.724-1.887 3.772-3.126 2.048-1.294 4.366-1.294 3.018 0 4.689 1.348 1.724 1.293 2.533 3.664 2.048-2.21 4.15-3.61 2.101-1.402 4.473-1.402 4.042 0 5.982 2.641 1.994 2.587 1.994 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.665-1.671-2.91 0-6.575 4.042V124.7h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.719-1.67-2.91 0-6.575 4.042v18.97zM861.21 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM886.27 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.886 7.384 1.887 2.64 5.336 2.64zM926.96 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.125-.646-2.102 0-3.827 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.887 7.384 1.886 2.64 5.335 2.64zM958.54 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM985.01 125.35q-3.45 0-6.252-1.617-2.802-1.617-4.42-4.689-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM999.23 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM1019.3 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.371-5.281 2.426-2.156 6.683-2.156 2.426 0 4.528.862 2.101.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1035.1 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809t2.101.809q.863.808.863 2.102 0 1.347-.863 2.155-.808.755-2.101.755zM1058.5 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69-2.748 1.616-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.101 2.748 5.443 2.748zM1077.5 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM1113.9 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862 2.102.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1131.9 125.35q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Better health." fill="#a53995" stroke-width="3.368">
          <path d="M699.58 187.95v-35.355h10.509q3.61 0 6.306.862 2.748.863 4.257 2.749 1.563 1.886 1.563 5.012 0 2.64-1.347 4.797-1.294 2.102-3.827 2.91v.216q3.18.592 5.174 2.694 2.048 2.102 2.048 5.767 0 3.45-1.724 5.767-1.671 2.317-4.69 3.449-3.017 1.132-7.005 1.132zm4.473-20.318h5.228q4.527 0 6.521-1.563 1.994-1.563 1.994-4.258 0-3.072-2.101-4.365-2.048-1.294-6.198-1.294h-5.444zm0 16.761h6.144q4.581 0 7.114-1.67 2.533-1.725 2.533-5.282 0-3.288-2.533-4.797-2.479-1.563-7.114-1.563h-6.144zM741.46 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM765.28 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM782.42 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM802.25 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM818.36 187.95v-26.193h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324t-1.348-.108q-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM847.84 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM887.78 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.586 5.982zM909.18 188.6q-3.288 0-5.497-1.94-2.156-1.994-2.156-5.498 0-4.311 3.826-6.575 3.88-2.317 12.234-3.233 0-1.671-.485-3.18-.43-1.51-1.616-2.426-1.132-.97-3.288-.97-2.264 0-4.258.863-1.994.862-3.557 1.94l-1.724-3.072q1.832-1.186 4.473-2.264 2.695-1.131 5.82-1.131 4.797 0 6.953 2.964 2.156 2.91 2.156 7.814v16.061h-3.665l-.377-3.125h-.162q-1.832 1.509-4.042 2.64-2.156 1.132-4.635 1.132zm1.294-3.557q1.886 0 3.556-.916 1.671-.916 3.557-2.587v-7.276q-6.52.808-9.162 2.425-2.587 1.617-2.587 4.15 0 2.21 1.348 3.234 1.347.97 3.287.97zM934.99 188.6q-2.48 0-3.61-1.509-1.079-1.563-1.079-4.42v-33.09h4.42v33.415q0 1.024.377 1.509.377.43.862.43h.377q.216-.053.593-.107l.593 3.341q-.431.216-1.024.324-.593.108-1.509.108zM952.29 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM962.26 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM993.9 188.6q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.563.916-2.479.97-.97 2.318-.97 1.294 0 2.21.97.97.917.97 2.48 0 1.455-.97 2.425-.917.916-2.21.916z"></path>
        </g>
      </svg>
    </div>
    <h1>Supplementary material 29 to: Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents</h1>
    <p>
      <span class="byline">Rajagopalan K, Hackl L, Pe&ntilde;a-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S</span>
      <br>
      <span class="doi"><a href="https://doi.org/10.1002/14651858.CD013227.pub2">https://doi.org/10.1002/14651858.CD013227.pub2</a></span>
    </p>
    <p>
      <span class="disclaimer">The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</span>
    </p>
    <div id="backToTop">
      <a href="#top">Back to top</a>
    </div>
    <h1>Description of interventions_5</h1>
    <div>
      <table>
        <tr>
          <th style="vertical-align: top;">
            <p>Item</p>
          </th><th style="vertical-align: top;">
            <p>Study ID</p>
          </th>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Eftekhari 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Iron and iodine cosupplementation among Iranian adolescent girls</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>adolescent girls in high school in Iran</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"To investigate whether iron supplementation can improve thyroid hormone function in iron-deficient adolescent girls."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"This was a double blind randomised placebo-controlled trial comparing supplementation for 12 weeks with iron, iodine, iron plus iodine, or placebo. Tablets containing 300mg of ferrous sulphate (i.e. 60mg/day of elemental iron) were obtained from the Daroupakhsh Company (Tehran, Iran) and were given at a dose of 1/day (5 days/week). A single oral dose of 190 mg of iodine in the form of a lipiodol capsule (ethyl esters of iodized fatty acids from poppy seed oil; 38% of lipiodol weight is iodine, Guerbet, France) was used for iodine supplementation (Zimmermann et al., 2000b).</p>
            <p>The supplements and placebos looked identical and were specially prepared for this study by the Daroupakhsh and Guerbet companies. The iron + iodine-treated group received a single oral dose of 190 mg of iodine in the form of lipiodol plus 300 mg ferrous sulphate 5 times/week. The iron-treated group received a single oral dose of lipiodol placebo capsule plus 300mg of ferrous sulphate 5 times per week. The iodine- treated group received a single oral dose of 190 mg of iodine lipiodol capsule plus iron placebo 5 times/week, and the control group received a one single lipiodol placebo capsule and iron placebo tablets 5 times a week.</p>
            <p>Participants were asked not to take any vitamins or iron supplements during the trial."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Demographic data, menstruation, any concurrent illness history, medication, and vitamin and mineral supplementa- tions were collected by interviews at baseline. Anthropome- try and food consumption were collected twice, at baseline and at the end of supplementation 12 weeks later. Body weight was measured to the nearest 0.1 kg using a Seca 713 scale while subjects were minimally clothed. Height was determined using measuring tape while subjects were with- out shoes, and body mass index was calculated by dividing weight (kg) by squared height (m2). The food consumption pattern was evaluated by a 24-h dietary recall questionnaire. Macro and micronutrient components were calculated by using Food Processor Software modified by incorporating the Iranian food table. At the beginning and end of the 12-week supplementation period, 10ml of fasting venous blood samples were drawn from the arm. Blood was collected in two tubes; 2ml were placed in the EDTA tube for measurement of haemoglobin and haematocrit and 8 ml in another tube for determination of serum albumin, TIBC, iron, ferritin, selenium, total and free thyroxine, total and free triiodothyronine, thyrotropin, T3RU and reverse triiodothyronine. In addition, urine samples were collected from the same subjects and on the same occasion as blood sampling for measurement of urinary iodine. Haemoglobin was measured using the cyanomethae- moglobin method (Dacie and Lewis, 1975), while serum iron (Ruutu, 1975), TIBC (Ceriotti and Ceriotti, 1980) and albumin (Doumus et al., 1971) were measured by the colorimetric method (Zist Chimie company lot. no.11&ndash;514, lot. no. 12&ndash;515 and lot. no. 10&ndash;502, respectively). Transferrin saturation was determined by dividing the serum iron concentration by the total iron binding capacity and multi- plying by 100. Serum ferritin, tT4, tT3, TSH, fT4, fT3, T3RU and rT3 were determined by radioimmunoassay (Henry, 1996), using commercially available kits (Belgium ZenTech for rT3 and American DSL for the rest). Selenium was measured by the atomic absorption method (Van Dael et al., 1995), and urinary iodine estimation was carried out using the digestion method (Dunn et al., 1993).</p>
            <p>Serum albumin was used as an indicator of malnutrition. Plasma selenium was measured because a low level of this trace element may have a negative effect on iodine metabolism, and urinary iodine was measured as an indicator of iodine deficiency."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>self-ingested and supervised by mothers and researchers</p>
            <p> 
            </p>
            <p>"The tablets for each girl were packed in small, labelled plastic bags. Student were asked not to drink tea or coffee when taking the tablets, which might have inhibited iron absorption and were advised to take them after meals in order to reduce the side effects of ingested tablets. Researcher and mothers supervised inges- tion of the supplements. If any girl reported unpleasant side effects of ingested tablets during the study, she was encouraged to continue the study but to take the supplement with a snack."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>individual</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>home-based</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>Group I: Iron + iodine: 190 mg of iodine in the form of lipiodol plus 300 mg ferrous sulphate 5 times/week; Group II: Iron: single oral dose of lipiodol placebo capsule plus 300 mg of ferrous sulphate 5 times per week;</p>
            <p>Group III: Iodine: single oral dose of 190 mg of iodine lipiodol capsule plus iron placebo 5 times/week; </p>
            <p>Group IV: placebo: one single lipiodol placebo capsule and iron placebo tablets 5 times a week</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"If any girl reported unpleasant side effects of ingested tablets during the study, she was encouraged to continue the study but to take the supple- ment with a snack"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Untoro 2005</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Effect of multiple micronutrient supplements on growth, morbidity, and iron status in Indonesian infants</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"284 infants aged 6-12"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"This study aimed to investigate the efficacy of multiple micronutrient supplements for improving micronutrient status, anemia, growth, and morbidity of Indonesian infants."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"Before the study, mothers of the selected infants were informed by the investigators about the purpose and the protocol of the study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Socioeconomic data were collected by a questionnaire after the guidelines for nutrition baseline surveys in communities, followed by all IRIS studies [<a href="#422228867955299683">1</a>]. Weight was recorded to the nearest 0.1 kg, with the child minimally clothed, using an electronic weighing scale (SECA 770). Length was recorded to the nearest 0.1 cm, with the child lying down, using the WHO [World Health Organization] recommended length-measuring board for infants (Ahrtag). The body weight and the height of the mothers were measured at the beginning of the study. Subjects were weighed without shoes, using an electronic platform model weighing scale (SECA 770 alpha; SECA) to the nearest 0.1 kg, and height was recorded to the nearest 0.1 cm using a microtoise [<a href="#422061599901842119">2</a>].</p>
            <p> 
            </p>
            <p>Child morbidity was measured in various ways during the 6-mo supplementation period. Whether the mother reported that the child had diarrhea (more than 4 runny stools), acute respiratory infection (cough, runny nose), or fever the day before was recorded. The mother was also asked about frequency of visits to health service to treat sickness of the child during the previous week.</p>
            <p> 
            </p>
            <p>Blood samples were collected at baseline and at the end of the study for biochemical analysis. Venous blood was collected using 2-mL vacuette heparin tubes with butterfly and luer adapters (Greiner). The tubes were immediately put in a cooled Styrofoam (Pt. Garinda) box and within 6 h were centrifuged at &sim;5000 &times; g for 5 min. Blood hemoglobin concentration was determined locally using the cyanomethemoglobin method [<a href="#422229037710054832">3</a>], in which 20 μL whole fresh blood from the vacuettes was mixed with 5 mL of Drabkin solution and measured by a standard photometer. The plasma was transferred into two 500 μL Eppendorf Safe Lock cups (at least 400 μL in the first one). Plasma was stored at &minus;70&deg;C until transportation on dry ice to the Micronutrient Laboratory, University of Hohenheim, Germany. All procedures were done as quickly as possible and were protected from direct light. To avoid the risk of zinc contamination, all tubes and tips were trace-element free and were handled very carefully to avoid contact with dust. To reduce variation, all supplies for blood collection and storage were from the same batch and were provided by the Micronutrient Laboratory. Plasma ferritin was measured by a standard ELISA procedure (DAKO). Plasma retinol and α-tocopherol were analyzed by HPLC [high-performance liquid chromatography] according to Erhardt et al. [<a href="#422228940962665898">4</a>]. Plasma zinc concentrations were analyzed by electrothermal atomic absorption spectrophotometry according to the manufacturer's instructions (Perkin Elmer). Riboflavin status was assessed by calculating the activation coefficient of the erythrocyte glutathione reductase (EGRAC), with and without added riboflavin [<a href="#422228965477062060">5</a>]. Plasma homocysteine levels were measured by HPLC [<a href="#422228995664516526">6</a>]. Plasma C-reactive protein (CRP), as an indicator of current infection, was assessed using the ELISA [enzyme-linked immunosorbent assay] procedure (DAKO)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"6 d/wk foodlets were given directly to the infants at their homes by trained field assistants under the supervision of the research team, with compliance recorded. On day 7, the mother gave the supplement to her infant...Child morbidity...mother reported...was also asked about frequency of visits to health service to treat sickness of the child during the previous week."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>individual, home-based administration</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"The study was conducted in the subdistricts of Salam and Ngluwar, in the district of Magelang, province of Central Java, Indonesia."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"Group 1 received the multiple micronutrient supplement on a daily basis (DMM group). The second group received a multiple micronutrient supplement on one day of the week plus a daily placebo for the other 6 d (WMM group). The third group received an iron supplement on a daily basis (DI group), and the fourth group received a placebo daily (P group)...The supplements developed were chewable tablets or foodlets, with the same color and flavor that would be attractive for toddlers (Roche Laboratories). The foodlets were packaged in identical-looking coded blister packs, each with 7 doses, one for each day of the week... The DMM supplement contained 15 micronutrients, including iron, zinc, copper, and iodine, and vitamins A, D, E, K, C, and B at the daily adequate intake level for young children (19). The WMM supplement had twice the daily adequate intake amounts of the same micronutrients but was only given on one day of the week; the P supplement was given the other days. The DI supplement contained 10 mg of iron as ferrous sulfate and was given daily. The P supplement contained no nutrients. In all groups, the foodlets were administered for 23 wk for 7 d/wk, of which 6 d/wk foodlets were given directly to the infants at their homes by trained field assistants under the supervision of the research team, with compliance recorded. On day 7, the mother gave the supplement to her infant."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"At the end of the supplementation trial, the placebo group was supplemented with the WMM supplement for 3 mo."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>"...supplementation from July 2000 through December 2000 for a period of 23 wk...was 2 wk shorter than the original plan of 25 wk, due to a Muslim festival celebrated by the majority of the subjects studied... If one family had more than one child that fulfilled the study requirements, all children were included and were treated individually but in the same intervention group. "</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"6 d/wk foodlets were given directly to the infants at their homes by trained field assistants under the supervision of the research team, with compliance recorded."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"A total of 260 of 284 subjects (92%) completed the study...Of those who dropped out, 22 subjects did not complete the study, either because they moved to another area or refused to continue the study or refused to participate in blood collection."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p> L&oacute;pez de Roma&ntilde;a 2005</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Efficacy of Multiple Micronutrient Supplementation for Improving Anemia, Micronutrient Status, Growth, and Morbidity of Peruvian Infants"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Three hundred and thirteen infants aged 6 to 12 mo"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"Anemia, micronutrient deficiencies, and growth faltering are still common in Peru. The study objective was to determine the efficacy of different micronutrient supplements in preventing growth failure, anemia, and micronutrient deficiencies in Peruvian infants."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"Before the inclusion of the child into the study, the mother received an explanation of possible risks and benefits, and a signed consent was obtained"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Before the supplementation trial, a baseline survey was carried out in all participating families after obtaining signed informed consent. A socioeconomic questionnaire and anthropometric measurements were obtained at the household level. Upon completion of the survey, all participating infants began receiving the supplements, which were administered at home on a daily basis. During the daily household visit, information was collected and coded on the acceptability of the supplement and infant morbidity on the previous day. All morbidity information was collected based on the mother's perception of presence or absence of symptoms. Diarrhea was defined as &ge;4 watery stools; upper respiratory infection was defined as presence of cough, runny nose, earache, or sore throat the previous day; and fever was defined as present or absent on the day of the visit. The information was summarized on a weekly and monthly basis.</p>
            <p> 
            </p>
            <p>Heparinized venous blood samples (10 mL) were collected at the beginning and the end of the trial at the nearest health post, for biochemical assessment of micronutrients. Hemoglobin (Hb) concentrations were analyzed locally using the cyanomethemoglobin method [<a href="#422229037710054832">3</a>]. Blood samples were stored immediately after collection in a precooled Styrofoam box (Productos Quimicos Pervanos) and were centrifuged within 6 h. Duplicate plasma and erythrocytes samples were transferred into 500-μL Eppendorf tubes and 500-μL Eppendorf Safe Lock cups, respectively. All plasma and erythrocyte samples were stored at &minus;70 C until their transportation in containers on dry ice to Germany, where they were analyzed at the Micronutrient Laboratory of the Institute of Biological Chemistry and Nutrition at the University of Hohenheim. Plasma ferritin was measured by a standard sandwich ELISA procedure from the provider of the antibodies (DAKO). Plasma zinc concentrations were analyzed by flame atomic absorption spectrophotometer according to the description of the manufacturer (Perkin Elmer). Plasma retinol and tocopherol levels were analyzed according to Erhardt et al. [<a href="#422229400861545959">7</a>]. Plasma homocysteine levels were measured by HPLC [<a href="#422228995664516526">6</a>], and riboflavin status was assessed by calculating the activation coefficient of the erythrocyte glutathione reductase (EGRAC) with and without added riboflavin [<a href="#422228965477062060">5</a>]. C-reactive protein (CRP) was measured as an indicator of short infection, by means of a Sandwich ELISA (DAKO).</p>
            <p>Anthropometric evaluations were carried out at the beginning and the end of the study in the nearest health post and on a monthly basis in the households. Infant's weight was measured and recorded to the nearest 0.1 kg with an electronic weighing scale (SECA) and with the infants minimally clothed. Length was recorded to the nearest 0.1 cm using the WHO recommended length-measuring board for infants (Ahrtag). Weight-for-age Z-score (WAZ), weight-for-height Z-score (WHZ), and height-for-age Z-score (HAZ) were calculated with EpiInfo 6.0 (Centers for Disease Control). Stunting and wasting were defined as &lt; &minus;2 Z-scores for height-for-age and weight-for-height, respectively, compared with international reference values; underweight and overweight were defined as &lt; &minus;2 Z scores of weight for age and &gt; 2 Z scores of weight for height, respectively [<a href="#422223210491677505">8</a>]."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"On 6 of the days, a trained field worker, under the supervision of the research team, gave the tablet directly to the infant and on 7th day, the mother gave the supplement to the infant."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>"The supplements were administered at home on a daily basis, 7 d/wk."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"...peri-urban communities of 2 cities in the department of Lambayeque (Lambayeque and Chiclayo), located <b>&sim;</b> 600 km north of Lima, the capital of Peru."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Infants were randomly assigned to receive 1 of 4 treatments,</p>
            <p>a daily placebo (P),</p>
            <p>a daily dose of 10 mg of iron as ferrous fumarate (DI),</p>
            <p>a DMM, or</p>
            <p>a weekly dose of multiple micronutrients (WMM).</p>
            <p>The daily supplement contained 15 micronutrients as follows: vitamin A (375 &micro;g), vitamin D (5 &micro;g), vitamin E (6 mg), vitamin K (10 &micro;g), vitamin C (35 mg), vitamin B-1 (0.5 mg), vitamin B-2 (0.5 mg),vitamin B-6 (0.5 mg), vitamin B-12 (0.9 &micro;g), niacin (6 mg), folic acid (150 &micro;g), iron as ferrous fumarate (10 mg), zinc as gluconate (5 mg),copper as gluconate (0.6 mg), and iodine (50 &micro;g). For the WMM study group, these amounts were doubled for consumption on one day of the week. The multiple micronutrient supplement was designed to provide the recommended daily intakes of children aged 1 to 2 y, with the exception of zinc...Supplements were manufactured as chewable, easy to break and to dissolve tablets in weekly coded blister packs. Three of the groups (P,DI, and DMM) had blister packs with 7 tablets of the same composition. The 4th group (WMM) had blister packs that included 6placebo tablets, and 1 tablet with micronutrients, which was always in the same position in the blister packs. The supplements were administered at home on a daily basis, 7 d/wk. &rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"Mothers of younger infants (6 to 8 mo), preferred to dissolve the tablets with a small amount of water in a teaspoon. For the older infants (8 to 12 mo), the preferred method was to divide the tablets into small pieces and to offer them to the children directly."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The supplements were administered at home on a daily basis, 7 d/wk. On 6 of the days, a trained field worker, under the supervision of the research team, gave the tablet directly to the infant and on 7th day, the mother gave the supplement to the infant."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The dropout rate was 12.5% during the 6-mo intervention period, with no difference in dropout rates between the treatment groups"</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Hop 2005</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Multiple micronutrient supplementation among Vietnamese infants</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>infants 6-12 months of age in Vietnam</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"to evaluate the efficacy of multiple micronutrient supplementation for improving nutrition status of infants from micronutrient deficient populations in rural Vietnam."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Trained NIN anthropometrists measured children&rsquo;s weight and length monthly. Weight was recorded to the nearest 0.1 kg, while children were minimally clothed, with an electronic weighing scale (SECA). Length was recorded to the nearest 0.1 cm using the WHO-recommended length-measuring board for infants (Ahrtag). Venous blood was drawn from the vein in the morning between 700 and 1100 at the commune health center and was transported to the micronutrient laboratory of NIN. Blood samples were taken at baseline and at the end of the intervention."</p>
            <p>""</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>health collaborator</p>
            <p>"The parents of infants were requested to take their infant every day to the house of the health collaborators selected in each village/ hamlet participating in the study. Treatments were numbered and were put in a plastic bag for each child and were given by the collaborators to infants each day, with one collaborator responsible for 5 to 10 infants. The commune health center workers supervised the quality of the work of the field collaborators weekly, and the National Institute of Nutrition (NIN) investigators visited the se- lected households twice per month."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>individual</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>house of the health collaborator</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Yurdak&ouml;k 2004</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Efficacy of Daily and Weekly Iron Supplementation on Iron Status in Exclusively Breast-Fed Infants"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Healthy 4-month-old, exclusively breast-fed infants attending the Hacettepe University Ihsan Dogramaci Children&rsquo;s Hospital Well Baby Clinic between March and June 1998"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"Iron deficiency anemia (IDA) remains the most prevalent nutritional deficiency in infants worldwide. The purpose of this study was to determine the efficacy of daily and weekly iron supplementation for 3 months to improve the iron status in 4-month-old, exclusively breast-fed healthy infants."<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"The purpose of the study was explained and verbal consent was obtained from the parents of eligible infants...Weaning recommendations were given to all mothers regularly when their infants were 6 months of age."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"At the initial appointment (4 months of age) infants were examined physically and weight, length, and head circumference were measured. During the enrollment period, 110 infant&ndash;mother pairs met the criteria, and simultaneous venous blood samples (3 mL) were obtained to assess their iron status (hemoglobin [Hb], mean corpuscular volume [MCV], serum iron, iron-binding capacity [SIBC], ferritin). Infants or mothers with ID [iron deficiency] or IDA [iron deficiency anaemia] on admission were given iron treatment and excluded...</p>
            <p> 
            </p>
            <p>A complete physical examination, including anthropometric measurements (weight, height, and head circumference), was performed for the infants and side effects were noted at 6 and 7 months of age. Hemoglobin, MCV, serum iron, ferritin levels, and SIBC of mother&ndash;infant pairs were determined monthly during the 3 months of supplementation. Transferrin saturation (TS) was calculated by dividing serum iron by SIBC...</p>
            <p> 
            </p>
            <p>Complete blood counts (Hb, hematocrit, MCV, red cell distribution width [RDW]) were determined using a Coulter Counter-S model (Coulter STKS, Coulter Corp., Hialeah, FL). Serum iron and iron-binding capacity were measured by colorimetric methods (Sigma) and serum ferritin by a commercial kit (Immulite 2000 Ferritin, Diagnostic Product Corp., Los Angeles, CA)...Data were analyzed using SPSS for Windows (SPSS Inc., Chicago, IL)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"All the mothers were instructed to give the iron supplements in the morning at least 1 hour before breast-feeding for 3 months."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>individual, "All the mothers were instructed to give the iron supplement"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"The iron supplement was given as a commercially available formulation (Ferrosanol&reg;, Schwarz Pharma AG, Mannheim, Germany) of ferrous sulfate suspension...</p>
            <p>the first group receiving daily (1 mg/kg daily),</p>
            <p>the second group weekly (7 mg/kg weekly), and</p>
            <p>the third group no iron supplementation...</p>
            <p>3 months of supplementation"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"When an infant or mother was detected to have IDA, the infant&ndash;mother pair was subsequently withdrawn from the study and referred for treatment...The iron dose was adjusted monthly according to the infant&rsquo;s weight."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Compliance with the study protocol and side effects were followed by weekly house calls."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"A total of 79 infants were recruited and randomized into three groups at 4 months of age. Three mothers (one from the control group, two from the weekly supplementation group) refused to continue the study. Five infants (two from the control group, three from the weekly supplementation group) were excluded due to early introduction of supplementary foods, including cow&rsquo;s milk. Two infants from the daily supplementation group contracted infectious diseases during the study period. In the daily supplementation group, two infants whose supplements had been stopped (both at 5.5 months of age) were considered noncompliant. All these infant&ndash;mother pairs were removed from the study. The total dropout rate was not significantly different among the groups (3/25 in the control group, 4/27 in the daily supplementation group, 5/27 in the weekly supplementation group, <i>P</i> &gt; 0.05)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p> Tsalis 2004</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Effects of iron intake through food or supplement on iron status and performance of healthy adolescent swimmers during a training season"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Forty-two (21 male and 21 female) swimmers, aged 12 - 17, without anemia or iron deficiency... belonged to a Greek swimming club"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"The purpose of this study was to investigate whether 1) the iron status of healthy adolescent swimmers changes during a training season of six months, and 2) increasing daily iron intake affects iron status or performance."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"The swimmers and their parents were informed about the design and probable risks of the research, and consented to participate...The participants were instructed not to consume any vitamin or mineral supplement (other than the experimental supplement) during the entire study period."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Subjects provided an initial blood sample for the determination of erythrocyte count, packed cell volume(PCV), hemoglobin, serum iron, total iron-binding capacity(TIBC), transferrin saturation, and ferritin...</p>
            <p> 
            </p>
            <p>Training protocol</p>
            <p> 
            </p>
            <p>All swimmers followed the same training program. The training period was divided into three phases, i.e., moderate intensity(endurance) training lasting three months, high intensity (power) training lasting two months, and tapering lasting one month. The average distance that they swam daily was 6 km during the first phase, 5 km during the second phase (of which approximately 15% was anaerobic training), and 3 km during tapering. Additionally, the swimmers performed dryland training (consisting of low intensity stretching and submaximal resistance exercises), three times per week, 45 min per session, during the first phase. Anthropometric measurementsBody mass and height were measured before the beginning of the study and at the end of each training phase. At the same time, body fat was estimated by bioelectrical impedance through the use of a Bodystat 1500 apparatus (Douglas, United Kingdom).Because bioelectrical impedance is influenced by the amount of body water, the participants were asked to abstain from any food or drinks for at least 4 h, physical exercise for at least 12 h, and caffeine containing beverages as well as sauna for at least 24 h before each measurement. Skeletal maturity was assessed in the middle of the study period through radiographs of the left hand of each swimmer according to the RUS method [<a href="#422330822075191097">9</a>]...</p>
            <p> 
            </p>
            <p>Morning fasting blood samples were taken from an antecubital vein in sitting position two days after the last training session on four occasions: before the beginning of the study and two days after the end of each training phase. An aliquot of each sample was mixed with EDTA [ethylenediaminetetraacetic acid] solution to prevent clotting, and erythrocyte count, PCV [packed cell volume], as well as hemoglobin concentration were measured in a Sysmex K-1000 (Kobe, Japan) hematological auto-analyzer. Serum was prepared from the remaining blood by centrifugation after clotting and was stored at -20&deg;C for the determination of iron, TIBC [total iron-binding capacity], transferrin saturation, and ferritin. Iron was assayed spectrophotometrically through a reagent kit fromB&ouml;hringer (Mannheim, Germany). TIBC was determined likewise after saturation of transferrin and precipitation of the excess of iron with a kit from Elitech (Sees, France). Transferrin saturation was calculated as the ratio of iron concentration to TIBC &rdquo; 100.Ferritin was determined by enzyme immunoassay with a kit from DRG (Marburg, Germany). All serum samples were analyzed concurrently at the completion of the study to eliminate variation in assay conditions...</p>
            <p> 
            </p>
            <p>Participants performed two identical tests, one at the beginning and one at the end of each training phase, for the assessment of performance. All swimming tests were performed in the morning and athletes abstained from any strenuous physical activity for two days before the tests. The tests flanking the first phase were at 2000 m, those flanking the second phase were at 800 m, and those flanking the third phase were at 200 m. These distances were selected in order to evaluate the accomplishment of the goals of each training phase. Additionally, the swimmers performed a 25-m sprint in water at the beginning of the study and at the end of each training phase for the determination of their maximal swimming velocity. Finally, at the beginning of each training phase, they performed a so-called two-speed test [<a href="#422330875974356901">10</a>] consisting of two 200-m swims with a 20-min interval for the assessment of the velocity corresponding to a blood lactate concentration of 4 mmol/l (V4). The first swim was at a velocity just below V4 and the second at a velocity just above V4. These velocities had been determined in previous routine tests. For lactate determination, capillary blood samples were taken from an ear-lobe one minute after the first bout and one as well as three minutes after the second bout. Blood was immediately mixed with an excess of 0. 6mol/l perchloric acid, and lactate was measured spectrophotometrically in the supernatant after centrifugation, using a kit from B&ouml;hringer. V4 was calculated linearly from the value after the first bout and the highest of the two values after the second bout...</p>
            <p> 
            </p>
            <p>All participants recorded their food intake daily during the entire study. Dietary records were analyzed for energy, carbohydrate,fat, protein, iron, calcium, folate, vitamin C, and fiber intake...</p>
            <p> 
            </p>
            <p>MenstruationFemale participants recorded the number of sanitary napkins they used during their menses, as a semi-quantitative index of blood loss."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>" One of the authors (GT) trained and monitored the athletes during all phases of the study.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"A. Subjects followed their regular diet and received one capsule of pharmaceutical ferrous sulfate containing 47 mg of iron over an empty stomach daily.</p>
            <p> 
            </p>
            <p>B. Subjects were given a six-day balanced dietary plan rich in iron, covering Monday through Saturday, whereas their diet was free on Sundays. The dietary plan met their energy requirements...The plan was repeated each week, but subjects were allowed to change the sequence of days.</p>
            <p> 
            </p>
            <p>C. Subjects followed their regular diet."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Athletes of group A were asked to return the vial containing the experimental capsules that they had been given at the beginning of the study so that their compliance could be determined."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Compliance was 96&#127; &plusmn; 3%."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Rosales 2004</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Effects of iron and/or zinc supplementation on nutrient status, oxidative stress, and inflammation</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"School children from low-income families, aged 8 to 11 years"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"The present study was conducted to assess whether a dose of iron, equivalent to twice the recommended daily allowance (RDA) for school-aged children [<a href="#422230123531474619">11</a>], would affect zinc status or induce oxidative stress and inflammation."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Blood samples were obtained at baseline before treatment allocation and 8 weeks later. Blood was extracted by venipuncture into heparinized vacutainers, and they were immediately placed in cool boxes at 6&deg;C. Aliquots of plasma were prepared after centrifugation of blood samples at 7000g for 10 min at 8&deg;C. Aliquots were frozen at &minus;70&deg;C in C0<sub>2</sub> and transported to the University of Hohenheim, Germany, where all biochemical determinations were done, or to the Pennsylvania State University, University Park, Pa, where immune assays were conducted...</p>
            <p> 
            </p>
            <p>Hemoglobin was measured in Guatemala using a commercial kit (Compur minilab 3, Bayer Diagnostic, Dublin, Ireland). Ferritin was measure using a sandwich enzyme-linked immunosorbent assay (ELISA) method [<a href="#422230206831925470">12</a>]. Iron deficiency was defined based on the general recommendation of a ferritin cutoff value of &lt;20 μg/L [<a href="#422230231268727008">13</a>]. Plasma zinc concentrations were determined by atomic absorption spectroscopy (AAS) using a Perkin-Elmer 1100 (Perkin-Elmer, Burladingen, Germany) with a hollow cathode lamp as described by Perry [<a href="#422238005406480606">14</a>]...Hypozincemia was defined based on plasma zinc concentrations &lt;10.7 μmol/L [<a href="#422238022384498912">15</a>]...</p>
            <p> 
            </p>
            <p>Antioxidant vitamins such as α-tocopherol and β-carotene were determined simultaneously by high-performance liquid chromatography after extraction with ethanol/butanol/butylated hydroxytoulene containing internal standards as previously described [<a href="#422229400861545959">7</a>]. The extracts were injected onto a C18 reversed-phase column eluted with acetonitrile-tetrahydrofuran-methanol-1% ammonium acetate (684:220:68:28, vol/vol/vol/vol), and full elution of all the analytes was realized isocratically within 10 minutes with UV detection of β-carotene at 450 nm and for α-tocopherol at 292 nm...</p>
            <p> 
            </p>
            <p>Malondialdehyde (MDA), measured as TBARS, was used to determine oxidation status because of its convenience in assessing in vivo lipid peroxidation [<a href="#422238046739249378">16</a>]. The determination of TBARS was performed as previously described by Jentzsch et al [<a href="#422238086499154150">17</a>]. Briefly, this method consists of using high concentration of ethanol/butanol/butylated hydroxytoulene to deplete oxygen and reducing the in vitro lipid peroxidation during TBARS adducts formation...</p>
            <p> 
            </p>
            <p>Acute phase proteins were measured by single radial immunodiffusion assay as previously reported [<a href="#422238108408625386">18</a>]. Positive APPs included AGP, CRP, and/or α-1 antichymotrypsin (ACT), and albumin as a negative APP to control for changes in zinc concentrations because 65% of circulating zinc is bound to albumin. Three positive APPs were selected because they differ in their onset and half-lives in response to an inflammatory stimulus. Antiserum for each protein and calibrators were purchased from DAKO Corporation (Carpinteria, Calif). Calibrators were titrated for each protein. Four different concentrations were selected for each assay. The College of American Pathologist's (Northfield, Ill) reference standard for plasma proteins was used as an external standard for all assays. The accuracy of each radial immunodiffusion assay was checked against two different dilutions of external standards. Quality control was conducted for each plate and the intra- and interassay coefficients of variation were determined before the experiment [<a href="#422238108408625386">18</a>]. The limit of detection is 1.0 mg/L for CRP, 0.03 g/L for ACT, and 0.01 g/L for AGP. Inflammation status was based on one or more APP concentrations being above their respective cutoff value, &ge;10 mg/L for CRP, &ge;1.0 g/L for AGP, and &ge;0.6 g/L for ACT [<a href="#422238141705107721">19</a>, <a href="#422238161656625421">20</a>]."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"Guatemala City, Guatemala"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"...placebo, iron alone, zinc alone, or iron and zinc combined... 20-mg dose of iron... zinc supplements were provided in a Zn-Fe ratio of 2:1...</p>
            <p>Thus, the iron-alone group received 3.3 mL of syrup containing 20 mg of elemental iron as iron citrate mixed with 50 mL of orange-flavored juice (ie, water, sugar, and artificial flavor). The zinc group received 5.0 mL of syrup containing 42.5 mg of elemental zinc as zinc sulfate mixed with 50 mL of orange-flavored juice, and the combined iron and zinc group received 3.3. mL of syrup containing 20 mg of elemental iron as iron citrate and 5.0 mL containing 42.5 mg of elemental zinc as zinc sulfate mixed with 50 mL of orange-flavored juice... Immediately after drinking the syrup, children received 50 mL fruit-flavored, nonvitaminized juice beverage in the same cup to rinse the vessel and ensure complete delivery of the dose of syrup. The supplementation period lasted 40 days over an 8-week period."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Children were followed up for 54 days, during which 12.5% (5/40) of girls and 16% (6/37) of boys missed 5 or more days of classes and did not receive at least 90% of the supplementation dosage; they were excluded from this efficacy analysis."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Nagpal 2004</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Effects of iron supplementation on haematological status in breastfed young infants in India initiated on complementary feeding</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"One hundred healthy non-low birth-weight, predominantly breastfed infants aged 4-6 months"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"There is a need to evaluate the effect of iron supplementation commencing, with the introduction of non-iron-fortified complementary foods, to healthy, term, breastfed infants aged 4-6 months. Limited information on the subject is available especially in India,where the bioavailability of iron from traditional cereal-based vegetarian complementary diets (rich in dietary inhibitors of iron absorption) is expected to be low, and the affordability of iron-fortified formulas is doubtful. We, therefore, conducted the current trial to evaluate the effect of an alternative of medicinal iron supplementation, commencing with the initiation of complementary feeding, to breastfed infants."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"...mothers were counselled to initiate complementary feeding (3-4 times a day)...with locally-available and home-made foods, such as banana, khichri (rice-pulse gruel cooked in oil), and dahlia(wheat cooked in milk). These natural foods were not supplemented or fortified with iron or other haematinic preparations. Both the groups were also advised to continue breastfeeding during the entire follow-up."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Follow-up visits were advised after four and eight weeks of recruitment...</p>
            <p> 
            </p>
            <p>A standard pre-tested proforma was used for recording baseline information, including antenatal and neonatal profiles, with emphasis on feeding history, birth-weight, and gestation. The dietary intake of infants was quantified by the 24-hour recall method (semi-quantitative estimates using home measures),and the calories were calculated as per values available for Indian foods [<a href="#422238539836308250">21</a>].</p>
            <p> 
            </p>
            <p>Maternal and infant weights, height/length, and current and interval morbidity(between two follow-up periods) were also recorded. The baseline haematological parameters evaluated included maternal haemoglobin and ferritin, and infant haemoglobin, peripheral smear, and serum ferritin.Haemoglobin was measured by the HemoCue system, which has been validated compared with other techniques [<a href="#422238571834391787">22</a>]. Serum ferritin was estimated using the MAGIWELL<sup>TM</sup> ferritin quantitative ELISA test kit. Maternal iron status was evaluated at baseline to control for its confounding effect on infant iron stores...</p>
            <p> 
            </p>
            <p>Data entry was done on the computer using EpiInfo software. Analysis was performed on EpiInfo and SPSS software."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>the supplement was provided to the child by the mother</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>home-based administration</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"Out-patient Department of a tertiary hospital in New Delhi, India, situated at an altitude of 210 metres. The hospital primarily caters to an urban lower to lower-middle socioeconomic population."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"The study group received iron in the form of medicinal drops (ferric ammonium citrate; 25mg/mL) at the dose of 2 mg/kg/day, while</p>
            <p>the control group received a placebo solution identical to iron drops in colour, taste, and external appearance."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Compliance of medicinal (iron or placebo) intake and feeding status were evaluated at each visit from a home diary maintained by the mother and verified by the amount of syrup leftover in the bottle. The drug intake estimated from the bottle and diary was similar."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"100 infants who fulfilled the recruitment criteria were enrolled for the prospective follow-up (49 in the iron-supplemented group and 51 in the placebo group). Seventy-one of the recruited infants (35 in the iron-supplemented group and 36 in the placebo group) reported for follow-up after one month. At the second follow-up (two months after recruitment), 43 of the 71infants at first follow-up (19 in the iron-supplemented group and 24 in the placebo group) were available."</p>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">
            <p>
              <b>ACT</b>:<b> </b>α-1 antichymotrypsin; <b>AGP</b>: α-1 acid glycoprotein; <b>CRP</b>: C-reactive protein; <b>d</b>: day(s); <b>EDTA</b>: ethylenediaminetetraacetic acid;<b> EGRAC</b>: erythrocyte glutathione reductase;<b> ELISA</b>: enzyme-linked immunosorbent assay; <b>HAZ</b>: height-for-age Z-scores;<b> Hb</b>: haemoglobin; <b>HPLC</b>: high-performance liquid chromatography; <b>ID</b>: iron deficiency; <b>IDA</b>: iron deficiency anaemia; <b>MCV</b>: mean corpuscular volume; <b>mo</b>: month(s); <b>PCV</b>: packed cell volume; <b>RE</b>: retinol equivalent; <b>SIBC</b>: serum iron, iron-binding capacity; <b>TIBC</b>: total iron-binding capacity;<b> TS</b>: transferrin saturation; <b>WAZ</b>: weight-for-age Z-scores; <b>WHO</b>, World Health Organization; <b>WHZ</b>: weight-for-height Z-scores;<b> wk</b>: weeks(s).</p>
            <p> 
            </p>
            <p>&mdash;: denotes not reported</p>
          </td>
        </tr>
      </table>
    </div>
    <h2>References</h2>
    <ol>
      <li id="422228867955299683">
        <span publication-type="other"><span person-group-type="author"><span><span>Gross</span> <span>R</span></span>, <span><span>Kielmann</span> <span>A</span></span>, <span><span>Korte</span> <span>R</span></span>, <span><span>Schoeneberger</span> <span>H</span></span>, <span><span>Schultink</span> <span>W</span></span></span>. <span>Nutrition baseline surveys in communities</span>. <span>Nutrition Surveys and Calculations: Guidelines, Software and additional Information</span>.</span>
      </li>
      <li id="422061599901842119">
        <span publication-type="book"><span person-group-type="author"><span><span>Gibson</span> <span>RS</span></span></span>. <span>Principles of Nutritional Assessment</span>. <span>London</span>: <span>Oxford University Press</span>, <span>1990</span>. </span>
      </li>
      <li id="422229037710054832">
        <span publication-type="book"><span person-group-type="author"><span>International Nutritional Anemia Consultative Group</span></span>. <span>Iron Deficiency in Women. Nutrition Foundation. A Report of the INACG Institute of Life Sciences</span>. <span>Washington, DC</span>: <span>Nutrition Foundation</span>, <span>1984</span>. </span>
      </li>
      <li id="422228940962665898">
        <span publication-type="journal"><span person-group-type="author"><span>Erhardt</span>, <span>Heinrich</span>, <span>Biesalski</span></span>. <span>Determination of retinol, antioxidant vitamins and homocysteine in skin puncture blood</span>. <span>International Journal for Vitamin and Nutrition Research</span> <span>1999</span>;<span>69</span>(<span>5</span>):<span>309-14</span>. [DOI: <a href="https://doi.org/10.1024/0300-9831.69.5.309">10.1024/0300-9831.69.5.309</a>]</span>
      </li>
      <li id="422228965477062060">
        <span publication-type="journal"><span person-group-type="author"><span><span>Bayoumi</span> <span>RA</span></span>, <span><span>Rosalki</span> <span>SB</span></span></span>. <span>Evaluation of methods of coenzyme activation of erythrocyte enzymes for detection of deficiency of vitamins B1, B2, and B6</span>. <span>Clinical chemistry</span> <span>1976</span>;<span>22</span>(<span>3</span>):<span>327-35.</span>. [DOI: <a href="https://doi.org/10.1093/clinchem/22.3.327">10.1093/clinchem/22.3.327</a>]</span>
      </li>
      <li id="422228995664516526">
        <span publication-type="journal"><span person-group-type="author"><span><span>Pfeiffer</span> <span>CM</span></span>, <span><span>Huff</span> <span>DL</span></span>, <span><span>Gunter</span> <span>EW</span></span></span>. <span>Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting</span>. <span>Clinical Chemistry</span> <span>1999</span>;<span>45</span>(<span>2</span>):<span>209-2</span>. [DOI: <a href="https://doi.org/10.1093/clinchem/45.2.290">10.1093/clinchem/45.2.290</a>]</span>
      </li>
      <li id="422229400861545959">
        <span publication-type="journal"><span person-group-type="author"><span><span>Erhardt</span> <span>JG</span></span>, <span><span>Mack</span> <span>H</span></span>, <span><span>Sobeck</span> <span>U</span></span>, <span><span>Biesalski</span> <span>HK</span></span></span>. <span>β-Carotene and α-tocopherol concentration and antioxidant status in buccal mucosal cells and plasma after oral supplementation</span>. <span>British Journal of Nutrition</span> <span>2002</span>;<span>87</span>(<span>5</span>):<span>471-5</span>. [DOI: <a href="https://doi.org/10.1079/BJN2002566">10.1079/BJN2002566</a>]</span>
      </li>
      <li id="422223210491677505">
        <span publication-type="journal"><span person-group-type="author"><span><span>Hamill</span> <span>PV</span></span>, <span><span>Drizd</span> <span>TA</span></span>, <span><span>Johnson</span> <span>CL</span></span>, <span><span>Reed</span> <span>RB</span></span>, <span><span>Roche</span> <span>AF</span></span>, <span><span>Moore</span> <span>WM</span></span></span>. <span>Physical growth: national center for health statistics percentiles</span>. <span>American Journal of Clinical Nutrition</span> <span>1979</span>;<span>32</span>(<span>3</span>):<span>607-29</span>. [DOI: <a href="https://doi.org/10.1093/ajcn/32.3.607">10.1093/ajcn/32.3.607</a>]</span>
      </li>
      <li id="422330822075191097">
        <span publication-type="book"><span person-group-type="author"><span><span>Tanner</span> <span>JM</span></span>, <span><span>Whitehouse</span> <span>RH</span></span>, <span><span>Marshall</span> <span>WA</span></span>, <span><span>Healy</span> <span>MJR</span></span></span>. <span>Assessment of skeletal maturity and prediction of adult height (TW2 method)</span>. <span>London</span>: <span>Academic Press</span>, <span>1983</span>. </span>
      </li>
      <li id="422330875974356901">
        <span publication-type="book-section"><span person-group-type="author"><span><span>Weltman</span> <span>A</span></span></span>. <span>The blood lactate response to exercise</span>. In: <span>Current issues in exercise science, monograph, no. 4</span>. <span>Champaign, IL</span>: <span>Human Kinetics</span>, <span>1995</span>:<span>83-5</span>.</span>
      </li>
      <li id="422230123531474619">
        <span publication-type="book"><span person-group-type="author"><span>The National Research Council</span></span>. <span>Recommended Dietary Allowances</span>. 10th edition. <span>Washington, DC</span>: <span>National Academy of Sciences</span>, <span>1989</span>. </span>
      </li>
      <li id="422230206831925470">
        <span publication-type="journal"><span person-group-type="author"><span><span>Zemelka</span> <span>S</span></span>, <span><span>Biesalski</span> <span>HK</span></span></span>. <span>Measurement of ferritin levels: comparison of a commercial IRMA to an in-house ELISA method</span>. <span>Journal of Immunoassay and Immunochemistry</span> <span>2001</span>;<span>22</span>(<span>4</span>):<span>371-84</span>. [DOI: <a href="https://doi.org/10.1081/IAS-100107401">10.1081/IAS-100107401</a>]</span>
      </li>
      <li id="422230231268727008">
        <span publication-type="journal"><span person-group-type="author"><span><span>Tershakovec</span> <span>AM</span></span>, <span><span>Weller</span> <span>SC</span></span></span>. <span>Iron status of Inner-city elementary school children: lack of correlation between anemia and iron deficiency</span>. <span>American Journal of Clinical Nutrition</span> <span>1991</span>;<span>54</span>(<span>6</span>):<span>1071-6</span>. [DOI: <a href="https://doi.org/10.1093/ajcn/54.6.1071">10.1093/ajcn/54.6.1071</a>]</span>
      </li>
      <li id="422238005406480606">
        <span publication-type="journal"><span person-group-type="author"><span><span>Perry</span> <span>DF</span></span></span>. <span>Flame atomic absorption spectrometric determination of serum zinc: collaborative study</span>. <span>Journal of the Association of Official Analytical Chemists</span> <span>1990</span>;<span>73</span>(<span>4</span>):<span>619-21</span>. [DOI: <a href="https://doi.org/10.1093/jaoac/73.4.619">10.1093/jaoac/73.4.619</a>]</span>
      </li>
      <li id="422238022384498912">
        <span publication-type="book"><span person-group-type="author"><span><span>Sauberlich</span> <span>HE</span></span></span>. <span>Laboratory Tests for the Assessment of Nutritional Status</span>. 2nd edition. <span>Washington DC</span>: <span>CRC Press LCC</span>, <span>1999</span>. </span>
      </li>
      <li id="422238046739249378">
        <span publication-type="journal"><span person-group-type="author"><span><span>Uehara</span> <span>M</span></span>, <span><span>Tateishi</span> <span>S</span></span>, <span><span>Chiba</span> <span>H</span></span>, <span><span>Suzuki</span> <span>K</span></span>, <span><span>Goto</span> <span>S</span></span></span>. <span>Effects of iron and copper supplementation on the formation of thiobarbituric acid-reactive substances and phosphatidylcholine hydroperoxide in the livers of iron-and copper-deficient rats</span>. <span>Journal of Nutritional Science and Vitaminology</span> <span>1998</span>;<span>44</span>(<span>5</span>):<span>705-14</span>. [DOI: <a href="https://doi.org/10.3177/jnsv.44.705">10.3177/jnsv.44.705</a>]</span>
      </li>
      <li id="422238086499154150">
        <span publication-type="journal"><span person-group-type="author"><span><span>Jentzsch</span> <span>AM</span></span>, <span><span>Bachmann</span> <span>H</span></span>, <span><span>F&uuml;rst</span> <span>P</span></span>, <span><span>Biesalski</span> <span>HK</span></span></span>. <span>Improved analysis of malondialdehyde in human body fluids</span>. <span>Free Radical Biology and Medicine</span> <span>1996</span>;<span>20</span>(<span>2</span>):<span>251-6</span>. [DOI: <a href="https://doi.org/10.1016/0891-5849(95)02043-8">10.1016/0891-5849(95)02043-8</a>]</span>
      </li>
      <li id="422238108408625386">
        <span publication-type="journal"><span person-group-type="author"><span><span>Rosales</span> <span>FJ</span></span>, <span><span>Topping</span> <span>JD</span></span>, <span><span>Smith</span> <span>JE</span></span>, <span><span>Shankar</span> <span>AH</span></span>, <span><span>Ross</span> <span>AC</span></span></span>. <span>Relation of serum retinol to acute phase proteins and malarial morbidity in Papua New Guinea children</span>. <span>American Journal of Clinical Nutrition</span> <span>2000</span>;<span>71</span>:<span>1582-8</span>. [DOI: <a href="https://doi.org/10.1093/ajcn/71.6.1582">10.1093/ajcn/71.6.1582</a>]</span>
      </li>
      <li id="422238141705107721">
        <span publication-type="journal"><span person-group-type="author"><span><span>Thompson</span> <span>D</span></span>, <span><span>Milford-Ward</span> <span>A</span></span>, <span><span>Whicher</span> <span>JT</span></span></span>. <span>The value of acute phase protein measurements in clinical practice</span>. <span>Annals of Clinical Biochemistry</span> <span>1992</span>;<span>29</span>(<span>2</span>):<span>123-31</span>. [DOI: <a href="https://doi.org/10.1177/000456329202900201">10.1177/000456329202900201</a>]</span>
      </li>
      <li id="422238161656625421">
        <span publication-type="journal"><span person-group-type="author"><span><span>Calvin</span> <span>J</span></span>, <span><span>Neale</span> <span>G</span></span>, <span><span>Fotherby</span> <span>KJ</span></span>, <span><span>Price</span> <span>CP</span></span></span>. <span>Annals of Clinical Biochemistry</span>. <span>1988</span> <span>25</span>;<span>1</span>:<span>60-6</span>. [DOI: <a href="https://doi.org/10.1177/000456328802500108">10.1177/000456328802500108</a>]</span>
      </li>
      <li id="422238539836308250">
        <span publication-type="book"><span person-group-type="author"><span><span>Gopalan</span> <span>C</span></span>, <span><span>Rama Sastri</span> <span>BV</span></span>, <span><span>Balasubramanian</span> <span>SC</span></span></span>. <span>Nutritive value of Indian foods</span>. <span>Hyderabad</span>: <span>National Institute of Nutrition, Indian Council of Medical Research</span>, <span>1993</span>. </span>
      </li>
      <li id="422238571834391787">
        <span publication-type="journal"><span person-group-type="author"><span><span>Lardi</span> <span>AM</span></span>, <span><span>Hirst</span> <span>C</span></span>, <span><span>Mortimer</span> <span>AJ</span></span>, <span><span>McCollum</span> <span>CN</span></span></span>. <span>Evaluation of the HemoCue&reg; for measuring intra‐operative haemoglobin concentrations: a comparison with the Coulter Max‐M&reg;</span>. <span>Anaesthesia</span> <span>1998</span>;<span>53</span>(<span>4</span>):<span>349-52</span>. [DOI: <a href="https://doi.org/10.1046/j.1365-2044.1998.00328.x">10.1046/j.1365-2044.1998.00328.x</a>]</span>
      </li>
    </ol>
  </body>
</html>
